Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 17, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 19, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-039287
Filed / recorded
Aug 19, 2026, 11:00 PM UTC
Added to OQRO
Oct 8, 2026, 2:37 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Calidi Biotherapeutics, Inc.
Issuer CIK
1855485
Ticker
CLDI
Reporting person
Eric E Poma
Relationship
Officer
Officer title
Chief Executive Officer
Security
Stock Options (right to buy)
Table
Derivative (Table II)
Transaction date
Aug 17, 2026
Transaction code
A
Shares / units
32,000
Acquired / disposed
Acquired (A)
Shares owned after
32,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
Pursuant to the Issuer's 2023 Equity Incentive Plan (the "2023 Plan"), on August 17, 2026 (the "Grant Date"), the Reporting Person was granted 32,000 incentive stock options (the "Options") at an exercise price of $1.36, which is equal to the closing price of the Issuer's common stock on the Grant Date. 25% of the options will vest upon the one (1) year anniversary of 08/17/2026, and the remaining 75% of the options will vest in 1/36th installments on a monthly basis, subject to the Reporting Person's continued service to the Issuer. The Options were granted in a transaction exempt under Rule 16b-3 to the Reporting Person.
Does not include the incentive stock options previously granted to the Reporting Person.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.